160 related articles for article (PubMed ID: 22222784)
1. Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: implication of accommodation.
Iwasaki K; Miwa Y; Ogawa H; Yazaki S; Iwamoto M; Furusawa T; Onishi A; Kuzuya T; Haneda M; Watarai Y; Uchida K; Kobayashi T
Transplantation; 2012 Feb; 93(4):390-7. PubMed ID: 22222784
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition.
Iwasaki K; Miwa Y; Uchida K; Kodera Y; Kobayashi T
Transpl Immunol; 2017 Feb; 40():22-30. PubMed ID: 28017877
[TBL] [Abstract][Full Text] [Related]
3. Antibodies directed against AB blood antigens or human leukocyte antigen molecules activate different intracellular pathways explaining their differential effects toward accommodation.
Le Bas-Bernardet S; Blancho G
Transplantation; 2012 Feb; 93(4):354-5. PubMed ID: 22277981
[No Abstract] [Full Text] [Related]
4. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway.
Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T
Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285
[TBL] [Abstract][Full Text] [Related]
5. Significance of HLA class I antibody-induced antioxidant gene expression for endothelial cell protection against complement attack.
Iwasaki K; Miwa Y; Haneda M; Uchida K; Nakao A; Kobayashi T
Biochem Biophys Res Commun; 2010 Jan; 391(2):1210-5. PubMed ID: 20006579
[TBL] [Abstract][Full Text] [Related]
6. AMP-activated protein kinase as a promoting factor, but complement and thrombin as limiting factors for acquisition of cytoprotection: implications for induction of accommodation.
Iwasaki K; Miwa Y; Haneda M; Kuzuya T; Ogawa H; Onishi A; Kobayashi T
Transpl Int; 2013 Nov; 26(11):1138-48. PubMed ID: 24047401
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms of Antibody-Mediated Rejection and Accommodation in Organ Transplantation.
Kenta I; Takaaki K
Nephron; 2020; 144 Suppl 1():2-6. PubMed ID: 33238285
[TBL] [Abstract][Full Text] [Related]
8. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.
Jin YP; Fishbein MC; Said JW; Jindra PT; Rajalingam R; Rozengurt E; Reed EF
Hum Immunol; 2004 Apr; 65(4):291-302. PubMed ID: 15120184
[TBL] [Abstract][Full Text] [Related]
9. The suppressive effect on CD4 T cell alloresponse against endothelial HLA-DR via PD-L1 induced by anti-A/B ligation.
Iwasaki K; Hamana H; Kishi H; Yamamoto T; Hiramitsu T; Okad M; Tomosugi T; Takeda A; Narumi S; Watarai Y; Miwa Y; Okumura M; Matsuoka Y; Horimi K; Muraguchi A; Kobayash T
Clin Exp Immunol; 2020 Nov; 202(2):249-261. PubMed ID: 32578199
[TBL] [Abstract][Full Text] [Related]
10. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
11. Molecular events contributing to successful pediatric cardiac transplantation in HLA sensitized recipients.
Sharma M; Webber SA; Zeevi A; Mohanakumar T
Hum Immunol; 2019 Apr; 80(4):248-256. PubMed ID: 30710563
[TBL] [Abstract][Full Text] [Related]
12. Accommodation: does it apply to human leukocyte antigens?
Rose ML; West LJ
Transplantation; 2012 Feb; 93(3):244-6. PubMed ID: 22167050
[TBL] [Abstract][Full Text] [Related]
13. Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway.
Narayanan K; Jaramillo A; Phelan DL; Mohanakumar T
Eur J Immunol; 2004 Aug; 34(8):2303-12. PubMed ID: 15259028
[TBL] [Abstract][Full Text] [Related]
14. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of the endothelial tie-2 crossmatch in ABO compatible and ABO incompatible renal transplants.
Kafetzi ML; Boletis JN; Melexopoulou CA; Tsakris A; Iniotaki AG; Doxiadis II
Hum Immunol; 2013 Nov; 74(11):1425-30. PubMed ID: 23792052
[TBL] [Abstract][Full Text] [Related]
16. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment.
Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME
Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810
[TBL] [Abstract][Full Text] [Related]
17. [The role of humoral antibodies in the rejection of a kidney allograft (a review of the literature)].
Drannik GN; Driianskaia VE
Vrach Delo; 1990 May; (5):45-9. PubMed ID: 2204199
[No Abstract] [Full Text] [Related]
18. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
19. Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective.
Biglarnia AR; Ekdahl KN; Nilsson B
Adv Exp Med Biol; 2015; 865():211-33. PubMed ID: 26306452
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
